A recent clinical study suggests that muscle ultrasound could be a noninvasive, cost-effective tool for identifying early signs of insulin resistance and reduced muscle mass in patients with obesity, potentially aiding in the early detection and intervention of type 2 diabetes and sarcopenia. The research involved 20 adult patients with obesity and lean controls, revealing strong associations between elevated muscle echo intensity (MEI) as measured by ultrasound and insulin resistance, impaired insulin sensitivity, and reduced muscle mass. The study highlighted the practical advantages of ultrasound over traditional methods, emphasizing its potential for widespread clinical and community use.

Source: Journal of Ultrasound in Medicine